Literature DB >> 22113472

Risk of herpes zoster in patients receiving anti-TNF-α in the prospective French RATIO registry.

Gaelle Serac, Florence Tubach, Xavier Mariette, Dominique Salmon-Céron, Philippe Ravaud, Frederic Lioté, David Laharie, Jean-Marc Ziza, Laurent Marguerie, Christine Bonnet, Geraldine Falgarone, Nathalie Nicolas, Olivier Lortholary, Olivier Chosidow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22113472     DOI： 10.1038/jid.2011.383

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  9 in total

1.  Disseminated Varicella Zoster Virus Infection with Encephalitis in a UC Patient Receiving Infliximab.

Authors:  Saleh M Elwir; Christopher C Shaffer; Susan W Arvan; Ethan F Kuperman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-01

Review 2.  Cutaneous Manifestations of Reactions to Biologics.

Authors:  Iris M Otani; Amy S Levin; Aleena Banerji
Journal:  Curr Allergy Asthma Rep       Date:  2018-02-21       Impact factor: 4.806

3.  Clinical characteristics of Nocardia infection in patients with rheumatic diseases.

Authors:  Mieko Yamagata; Koichi Hirose; Kei Ikeda; Hiroshi Nakajima
Journal:  Clin Dev Immunol       Date:  2013-09-19

Review 4.  Determinants of neurological syndromes caused by varicella zoster virus (VZV).

Authors:  Peter Ge Kennedy; Trine H Mogensen
Journal:  J Neurovirol       Date:  2020-06-03       Impact factor: 2.643

Review 5.  Herpes Zoster in Patients Receiving JAK Inhibitors For Ulcerative Colitis: Mechanism, Epidemiology, Management, and Prevention.

Authors:  Jean-Frédéric Colombel
Journal:  Inflamm Bowel Dis       Date:  2018-09-15       Impact factor: 5.325

6.  Risk of herpes zoster associated with biological therapies for psoriasis and psoriatic arthritis: A systematic review and meta-analysis.

Authors:  Ailing Zou; Yongjun Chen; Nian Shi; Yu Ye
Journal:  Medicine (Baltimore)       Date:  2021-10-08       Impact factor: 1.889

7.  Seborrhoeic dermatitis and a herpes zoster infection developed during treatment with adalimumab due to Crohn's disease.

Authors:  Beata Bergler-Czop; Dominika Wcisło-Dziadecka; Karolina Wodok; Ligia Brzezińska-Wcisło
Journal:  Postepy Dermatol Alergol       Date:  2015-08-12       Impact factor: 1.837

Review 8.  Herpes zoster in psoriasis patients undergoing treatment with biological agents: prevalence, impact, and management challenges.

Authors:  Lara El Hayderi; Fany Colson; Bita Dezfoulian; Arjen F Nikkels
Journal:  Psoriasis (Auckl)       Date:  2016-10-18

Review 9.  Incidence, Clinical Features, Management, and Prevention of Herpes Zoster in Patients Receiving Antitumor Necrosis Factor Therapy: A Clinical Review.

Authors:  Byung-Soo Kim; Emanual Maverakis; Clarie Alexanian; Jenny Z Wang; Siba P Raychaudhuri
Journal:  J Cutan Med Surg       Date:  2020-04-02       Impact factor: 2.092
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.